S2-E29.2 – Previewing Digital ILC 2021 — Part 1 — Interests and Issues

EASL Scientific Committee member Luca Valenti joins the Surfers to discuss some of the issues that will be discussed at Digital ILC 2021.

After Luca and Stephen Harrison discuss what they consider highlights of this month’s Digital ILC meeting, Louise Campbell and Roger Green join them to discuss some of the key issues they anticipate being address at EASL’s signature annual event.

TOPICS: COVID-19, Diabetes, Diagnostic Tests, DrugTrial, Fatty Liver, NAFLD, NASH, Obesity, Lifestyle interventions, polygenic risks, multidisciplinary management, renal disease, cardiovascular disease, co-ordinated care, liver cancer, HCC

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast

The NASH Tsunami In Diabetes

Categories for NASH Tsunami
AASLD Allied Health Professionals Cirrhosis Clinical Trials Companies COVID-19 Diabetes Diagnostics Doctors Drugs/Drug Classes Drug therapies Endocrinology clinics Epidemiology Fatty Liver FDA FIB-4 GLP-1s Guidelines Hepatology Histopathology Inside The Vault Investors Liver Science Major Meetings Metabolic Diseases Motivating front-line treaters NAFLD NAFLD Prevalence NAIL-NIT NASH NASH-TAG NASH/Diabetes Co-Morbidity NITs Obesity Patient Advocacy Patients Pediatric NASH Podcast Prevalence/Incidence Public Health Rising Tide Science Special Subpopulations Suggested Reading Type 2 Diabetes Mellitus

Listen Now

Apple Spotify Youtube
Copyright © SurfingNASH.Com 2020—2023
Linkedin Facebook Twitter Instagram
Stay In Touch
Apple Spotify Youtube